Tag: Neural Analytics
NeuralBot system receives US FDA clearance
Neural Analytics has announced that it has received US Food and Drug Administration (FDA) 510(k) clearance for its NeuralBot System, a robotic assistance technology...
Portable transcranial doppler technology can accurately measure strokes
Medical device company Neural Analytics has announced the results from the first phase of the EXPEDITE (Evaluate a next generation portable diagnostic platform for determination and immediate triage of emergency...
Lucid System gets software update
Neural Analytics has released the latest system update for its next generation ultrasound device, the Lucid M1 Transcranial Doppler Ultrasound System.
The Lucid System is...
Portable transcranial Doppler technology assesses stroke with >95% accuracy
Initial results of the EXPEDITE clinical study have shown Neural Analytics’ Transcranial Doppler technology platform , to be more than 95% accurate for the...
Neural Analytics raises US$10 million in new funding round
Neural Analytics, a medical device company developing and commercialising technology to measure, diagnose and track brain health, announced today that it has raised US$10...
Neural Analytics introduces Lucid M1 Transcranial Doppler Ultrasound System
Neural Analytics has announced the commercial launch of its Lucid M1 Transcranial Doppler Ultrasound System, a portable brain monitoring system designed to measure cerebral blood flow velocities...
FDA clears portable brain monitoring information system
The US Food and Drug Administration has granted 510(k) for the Lucid M1 Transcranial Doppler Ultrasound System. The Lucid System is the first FDA...
First patient enrolled in EXPEDITE study to evaluate portable diagnostic platform...
The first patient has been enrolled in the EXPEDITE (Evaluate a next generation portable diagnostic platform for determination and immediate triage of emergency large vessel stroke) phase I clinical study...
